CAS 1628614-50-5 appears in our catalog under these names: XMD–17–51, XMD-17-51. Offered by: GLPBio, TargetMol, MedChemExpress, Chemat. Available pack sizes: 50mg, 25mg, 100mg, 10mg, 200mg, Get quote, 1mg.
XMD-17-51 is a pyrimidobenzodiazepine this is 5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one substituted by methyl groups at positions 5 and 11, and by a [1-(piperidin-4-yl)-1H-pyrazol-4-yl]amino group at position 2. It is an inhibitor of NUAK1. It has a role as an antineoplastic agent and an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor. It is a member of piperidines, a member of pyrazoles, an aromatic amine, a secondary amino compound, a tertiary amino compound and a pyrimidobenzodiazepine.
Source: ChEBI
| Molecular formula | C21H24N8O |
|---|---|
| Molecular weight | 404.5 g/mol |
| IUPAC name | 5,11-dimethyl-2-[(1-piperidin-4-ylpyrazol-4-yl)amino]pyrimido[4,5-b][1,4]benzodiazepin-6-one |
| InChIKey | LKOFXMLMYKWELM-UHFFFAOYSA-N |
| SMILES | CN1C2=CC=CC=C2C(=O)N(C3=CN=C(N=C31)NC4=CN(N=C4)C5CCNCC5)C |
Computed by PubChem (NCBI)